Free Trial

Harvest Fund Management Co. Ltd Invests $484,000 in Xometry, Inc. (NASDAQ:XMTR)

Xometry logo with Industrials background
Remove Ads

Harvest Fund Management Co. Ltd purchased a new position in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 11,348 shares of the company's stock, valued at approximately $484,000.

Other institutional investors have also recently bought and sold shares of the company. Barclays PLC lifted its position in Xometry by 360.9% during the third quarter. Barclays PLC now owns 68,951 shares of the company's stock worth $1,266,000 after purchasing an additional 53,991 shares during the period. Weiss Asset Management LP bought a new position in shares of Xometry in the 3rd quarter valued at $1,586,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Xometry during the 3rd quarter worth $355,000. Primecap Management Co. CA grew its position in Xometry by 1.7% in the third quarter. Primecap Management Co. CA now owns 6,918,252 shares of the company's stock valued at $127,088,000 after acquiring an additional 113,264 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Xometry by 4.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 354,849 shares of the company's stock valued at $6,519,000 after purchasing an additional 16,396 shares during the last quarter. Institutional investors own 97.31% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. JMP Securities reaffirmed a "market outperform" rating and issued a $42.00 target price on shares of Xometry in a report on Monday, February 10th. Wedbush reaffirmed an "outperform" rating and set a $48.00 price target on shares of Xometry in a research note on Friday, December 20th. Royal Bank of Canada boosted their price objective on shares of Xometry from $27.00 to $40.00 and gave the stock a "sector perform" rating in a research note on Friday, January 3rd. UBS Group lifted their price objective on Xometry from $22.00 to $33.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 26th. Finally, JPMorgan Chase & Co. raised shares of Xometry from a "neutral" rating to an "overweight" rating and increased their target price for the company from $25.00 to $45.00 in a research report on Wednesday, December 18th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $36.11.

Remove Ads

Check Out Our Latest Report on XMTR

Xometry Trading Down 1.2 %

Shares of Xometry stock traded down $0.31 on Wednesday, reaching $26.50. 421,616 shares of the company's stock were exchanged, compared to its average volume of 596,741. The company has a market capitalization of $1.33 billion, a P/E ratio of -25.24 and a beta of 0.69. Xometry, Inc. has a 52 week low of $11.08 and a 52 week high of $45.33. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.55 and a current ratio of 4.59. The firm's 50-day moving average is $30.99 and its two-hundred day moving average is $28.95.

Insider Buying and Selling

In other Xometry news, CFO James Miln sold 25,852 shares of the stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $24.06, for a total value of $621,999.12. Following the transaction, the chief financial officer now owns 105,238 shares in the company, valued at approximately $2,532,026.28. This represents a 19.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Peter Goguen sold 940 shares of the business's stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $42.36, for a total value of $39,818.40. Following the sale, the chief operating officer now owns 167,993 shares of the company's stock, valued at approximately $7,116,183.48. This represents a 0.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 73,965 shares of company stock valued at $2,050,643 over the last ninety days. 16.79% of the stock is owned by corporate insiders.

Xometry Profile

(Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Featured Articles

Institutional Ownership by Quarter for Xometry (NASDAQ:XMTR)

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

The Future of Healthcare: 3 AI Stocks Leading the Way

The Future of Healthcare: 3 AI Stocks Leading the Way

2025 promises explosive growth for AI, but which companies are making a difference in healthcare? Chris Markoch highlights three stocks leading the charge.

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads